2025. COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY. The Research of Medical Science Review. 3, 6 (Jun. 2025), 94–100.